[Limited

The “Honseikai Takayama Hospital Edition” of “Waculba Executive Dialogue” released by Nihon Keiei presents the value of choosing third-party succession instead of closure or discontinuation of business when facing succession issues for medical corporations. It is inferred that the content suggests the importance for chairpersons/hospital directors to start preparations 5 to 10 years before turning 60, and that utilizing specialized advisors in the healthcare industry is key to achieving smooth business succession.

Learning from the Honseikai Takayama Hospital Case: Third-Party Succession for the Continuation of Community Healthcare

The “Honseikai Takayama Hospital Edition” of “Waculba Executive Dialogue,” released for a limited time by Nihon Keiei, is noteworthy for presenting realistic business succession options through a specific case study of a medical corporation. The significance of choosing third-party succession instead of closure or discontinuation of business, in response to the succession issues faced by many medical corporations, is extremely high. Particularly for hospitals and clinics that play a central role in the community, their closure not only significantly impairs residents’ access to medical care but also directly leads to job losses for healthcare professionals working there. The case of Honseikai Takayama Hospital is presumed to concretely demonstrate the value of third-party succession in passing on existing medical resources (facilities, equipment, personnel, patient base) to the next generation, thereby contributing to the maintenance and development of the regional healthcare delivery system. For medical corporations with equity interests, the valuation of equity interests and the setting of transfer consideration become important issues, while for medical corporations without equity interests, various methods such as fund contributions, business transfer, or merger will be considered.

“5 to 10 Years from Around Age 60”: A Long-Term Preparation Strategy for Successful Medical M&A

The specific timeframe mentioned in the news summary, “chairpersons/hospital directors preparing 5 to 10 years from around age 60,” succinctly illustrates how medical institution M&A and business succession require a long-term perspective and strategic planning. The need for this period stems from complex factors unique to medical corporations that are not present in general corporate M&A.

• Enhancing and Maintaining Business Value: During the 5 to 10 years leading up to succession, efforts can be made to enhance business value, such as improving financial health, reorganizing medical departments, maintaining and upgrading facility standards, and responding to revisions in medical fees.
• Organizational Structure Development: Preparations for smooth transfer of management rights are necessary, including reviewing the composition of board members and employees, formulating succession plans for key healthcare professionals, and procedures for changing officers under the Medical Care Act.
• Legal and Tax Measures: Especially for medical corporations with equity interests, since the valuation of equity interests directly impacts capital gains tax, it is essential to collaborate with a tax accountant from an early stage to implement appropriate tax measures. Furthermore, procedures under the Medical Care Act and various notifications to public health centers also require time.
• Confirmation of Licenses, Permits, and Notifications: The confirmation and renewal of various licenses and permits based on the Medical Care Act, as well as matters related to medical fee claims, must also be systematically advanced during this period.

Neglecting these preparations increases the risk of M&A negotiations becoming difficult or succession not being realized under desired conditions.

Specificity of Utilizing Expert Advisors in Medical M&A

The utilization of specialized advisors in the healthcare industry, such as “Nihon Keiei,” is indispensable for smoothly navigating the complex processes mentioned above. Unlike M&A for general operating companies, medical M&A requires a deep understanding of a wide range of healthcare-related laws, including the Medical Care Act, the Medical Practitioners’ Act, and the Public Health Nurses, Midwives and Nurses Act. Specialized advisors provide the following specific support:

• Healthcare-Specific Due Diligence: They professionally analyze evaluation items unique to medical institutions, such as patient demographics, claims data analysis, qualifications and expertise of doctors and nurses, and compliance with facility standards.
• Support for Succession of Healthcare Professionals: They provide expertise on maintaining the motivation of key healthcare professionals such as doctors and nurses, and ensuring a smooth transition after succession. This is an extremely important factor for the continuous operation of a medical institution.
• Specialized Legal, Tax, and Financial Support: They collaborate with lawyers and tax accountants specializing in medical corporation M&A to resolve complex legal, tax, and financial issues.
• Response to Regional Healthcare Vision: They may also provide advice on post-succession business strategies from a macro perspective, such as regional healthcare visions and reorganization of bed functions.

The case of Honseikai Takayama Hospital can be said to be a good example of how the expertise of specialized advisors contributes to strategic decisions that go beyond mere sales contracts, influencing the sustainability of medical institutions and the future of community healthcare.

If you are specifically considering succession or M&A for a medical corporation or clinic, please utilize our free quick assessment or individual consultation (strict confidentiality and entirely success-based fee system).